We found that JSI-124 (1 mg/kg/day) significantly suppressed tumor volume and tumor weight without any side effects on mice, and remarkably reduced neovascularization accompanied by down-regulation expression of p-STAT3 and p-VEGFR2. The gene discussed is KDR; the disease is neoplasm.